Vanderbilt ends fast-tracked Covid-19 study

Vanderbilt ends fast-tracked Covid-19 study

bizjournals

Published

Researchers with a fast-tracked Covid-19 study led by Vanderbilt University ended their efforts this weekend. According to 90.3 WPLN Nashville Public Radio, the study was researching potential benefits of taking hydroxychloroquine, an anti-malarial medication that President Donald Trump repeatedly described as promising for treating the coronavirus. The study, which was announced in April, found no benefits of treating Covid-19 patients with the medication, WPLN reports. WPLN reports that the…

Full Article